The immuno-oncology treatment developer secured series B funding from investors including Legend Capital, a year after its $50m series A round.

MUFG Innovation Partners contributed to mobility financier Moove's $105m series A2 round while MS&AD and Nationwide helped insurance software developer Socotra raise $50m.

The healthcare provider has added $25m to its original commitment of $25m for TMC Venture Fund, to be deployed over the next decade.

SAIC Motor’s Hengxu Capital helped allosteric drug developer Nutshell Therapeutics close a $40m round while cancer therapy developer Impact Therapeutics secured series D1 funding.

NGT HealthCare II Impact Fund has raised a $92m fund with T3 and Hadassit joining as strategic partners.

GV returned for a multimillion dollar round raised by the clinical data software provider, which is part of a space of much interest to corporate investors.

Lunar expanded its series D round to $307m while RefleXion Medical raised $80m and Silent Eight raked in $40m.

SATT Aquitaine has signed up INRAE and its tech transfer arm for a five-year agreement to help commercialise its research.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Texas Medical Center has committed another $50m to its TMC Venture Fund, to be deployed over the next decade, adding to its original commitment of $25m in 2017.